Search Login Register

Epidermal Growth Factor (EGF) Summary

Description: A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. EPIDERMAL GROWTH FACTOR exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and epithelial cells.

Also Known As: EGF; Epidermal Growth Factors; Human Urinary Gastric Inhibitor; beta-Urogastrone; Growth Factor, Epidermal Show All >>

Networked: 9462 relevant articles (253 outcomes, 1209 trials/studies) for this Bio-Agent

Key Diseases for which Epidermal Growth Factor is Relevant

  1. Neoplasms (Cancer) : 68 outcomes 249 studies in 2850 results
  2. Breast Neoplasms (Breast Cancer) : 23 outcomes 139 studies in 1108 results
  3. Wounds and Injuries (Trauma) : 19 outcomes 60 studies in 390 results
  4. Ulcer : 13 outcomes 34 studies in 167 results
  5. Glioma (Gliomas) : 10 outcomes 35 studies in 221 results
Show All >>

Drugs Related to Epidermal Growth Factor

  1. Epidermal Growth Factor (EGF)
  2. Epidermal Growth Factor Receptor (EGF Receptor)
  3. trastuzumab (Herceptin)
  4. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
  5. Intercellular Signaling Peptides and Proteins (Growth Factors)
  6. cetuximab (Erbitux)
  7. Protein-Tyrosine Kinases (Tyrosine Kinase)
  8. Transforming Growth Factor alpha (TGF-alpha)
  9. DNA (Deoxyribonucleic Acid)
  10. Heparin (Liquaemin)
Show All >>

Therapies Related to Epidermal Growth Factor

  1. Drug Therapy (Chemotherapy)
  2. Radiotherapy
  3. Heterologous Transplantation (Xenotransplantation)
  4. Enema (Enemas)
  5. Transplantation (Transplant Recipients)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.